Implementation of a Dual-Column Liquid Chromatography-Tandem Mass-Spectrometry Method for the Quantification of Isavuconazole in Clinical Practice

Isotope dilution LC-orbitrap-HRMS with automated sample preparation for the simultaneous quantification of 11 antimycotics in human serum

(2019) Carina Schuster et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Evaluation of a commercial liquid-chromatography high-resolution mass-spectrometry method for the determination of hepcidin-25

(2019) Dietmar Enko et al.   Biochemia Medica

Experience with therapeutic drug monitoring of three antifungal agents using an LC-MS/MS method in routine clinical practice

(2019) Sun Joo Yoon et al.   CLINICAL BIOCHEMISTRY

Isavuconazole for treatment of rare invasive fungal diseases

(2018) Oliver A. Cornely et al.   MYCOSES

Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species

(2018) Francisco M. Marty et al.   MYCOSES

Validation of an Isavuconazole High-Performance Liquid Chromatography Assay in Plasma for Routine Therapeutic Drug Monitoring Applications

(2018) Silke C. Mueller et al.   THERAPEUTIC DRUG MONITORING

The right blood collection tube for therapeutic drug monitoring and toxicology screening procedures: Standard tubes, gel or mechanical separator?

(2018) Aurélien Schrapp et al.   CLINICA CHIMICA ACTA

Reliable and Easy-To-Use Liquid Chromatography–Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum

(2017) Carsten Müller et al.   THERAPEUTIC DRUG MONITORING

Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi

(2016) Amit Desai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

(2016) Johan A Maertens et al.   LANCET

Serially coupling hydrophobic interaction and reversed-phase chromatography with simultaneous gradients provides greater coverage of the metabolome

(2015) Jennifer Haggarty et al.   Metabolomics

LC–MS/MS in the routine clinical laboratory: has its time come?

(2013) Kelvin Sze-Yin Leung et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology

(2013) H. R. Ashbee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections

(2012) Joanne Livermore et al.   Expert Opinion on Drug Metabolism & Toxicology

Screening ionisation and chromatography conditions for quantitative LC/MS methods

(2009) Henrik Sillén et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Serial coupling of reversed-phase and hydrophilic interaction liquid chromatography to broaden the elution window for the analysis of pharmaceutical compounds

(2008) Stefan Louw et al.   JOURNAL OF CHROMATOGRAPHY A